| titleOfInvention |
Use of (r) –2– [4– (2– fluorobenzyloxy) –benzylamino] propanamide or (r) –2– [4– (2 chlorobenzyloxy) –benzylamino] - n– methyl propanamide for the preparation of drugs that act selectively as modulators of sodium channels And / or calcium and which lack or have a low effect as monoamine oxide inhibitors |